Principal Healthcare Innovators ETF (BTEC)
| Assets | $38.73M |
| Expense Ratio | 0.42% |
| PE Ratio | n/a |
| Shares Out | 1.07M |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Ratio | n/a |
| 1-Year Return | -3.79% |
| Volume | 52 |
| Open | 35.85 |
| Previous Close | 36.17 |
| Day's Range | 35.65 - 35.85 |
| 52-Week Low | 25.66 |
| 52-Week High | 39.75 |
| Beta | 1.24 |
| Holdings | 271 |
| Inception Date | Aug 19, 2016 |
About BTEC
Fund Home PageThe Principal Healthcare Innovators ETF (BTEC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio. BTEC was launched on Aug 19, 2016 and is issued by Principal.
Top 10 Holdings
24.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Moderna, Inc. | MRNA | 3.64% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.21% |
| Sarepta Therapeutics, Inc. | SRPT | 2.63% |
| Illumina, Inc. | ILMN | 2.57% |
| Natera, Inc. | NTRA | 2.45% |
| Catalent, Inc. | CTLT | 2.15% |
| Exact Sciences Corporation | EXAS | 2.08% |
| Roivant Sciences Ltd. | ROIV | 1.93% |
| Viking Therapeutics, Inc. | VKTX | 1.87% |
| Elanco Animal Health Incorporated | ELAN | 1.81% |
News
Best Biotech ETFs for Q1 2021
The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.
3 Health Care ETFs Where Components Are Enduring Downgrades
After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.
3 ETFs To Play Gilead's $21B Immunomedics Takeover
Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.
3 ETFs For More Moderna Bets
Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
3 Biotech ETFs Up 10% Or More Over The Last Month
Something's been brewing in the health care sector, the second-largest group in the S&P 500.